Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease.
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Glial contributions to neural function and disease.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Enrollment complete for cannabinoid MS study
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
The pill times 2: What every woman with multiple sclerosis should know.
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
JC viremia in natalizumab-treated patients with multiple sclerosis.
Multiple Sclerosis: Myeloperoxidase Immunoradiology Improves Detection of Acute and Chronic Disease in Experimental Model.
Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.

Pages